Mechanisms and recent advances in therapy of hypertension

4th International Symposium on Nephrology, Hannover, June 18-19, 1976
  • 236 Pages
  • 4.31 MB
  • 7109 Downloads
  • English
by
S. Karger , Basel, New York
Hypertension -- Congresses., Hypotensive agents -- Congre
Statementvol. editors, H. Liebau and J. Brod.
SeriesContributions to nephrology ;, v. 8
ContributionsLiebau, H., Brod, J.
Classifications
LC ClassificationsRC685.H8 I47 1976
The Physical Object
Pagination236 p. :
ID Numbers
Open LibraryOL4286711M
LC Control Number78313520

Add tags for "Mechanisms and recent advances in therapy of hypertension: 4th International Symposium on Nephrology, Hannover, Mechanisms and recent advances in therapy of hypertension book". Be the first. Similar Items. RECENT ADVANCES IN THERAPY FOR HYPERTENSION A.

HEAGERTY It is axiomatic that man requires an adequate arterial pressure to maintain tissue perfusion. However, diseases of the circulation are observed more frequently in subjects at the upper end of what is a normal distribution of pressures: thus the association between hypertension and cardio.

TY - JOUR. T1 - Recent advances in the management of hypertension. AU - Leon, A. PY - /1/1. Y1 - /1/1. N2 - Advances during the past 4 decades in the management of hypertension include the following: a clearer understanding of the precursors of essential hypertension; encouraging attempts at primary prevention in high-risk individuals and in entire populations; establishment by Cited by: 7.

Recent advances in the treatment of hypertension Article Literature Review (PDF Available) in Expert Review of Cardiovascular Therapy 9(6) June with Reads How we measure 'reads'. complementary mechanisms. Angiotensin-converting. Recent advances in hypertension Al-Nozha & Khalil Diuretics are currently recommended as first-line therapy.

Accepted for Publication: February combination. 29, RECENT ADVANCES IN THERAPY FOR HYPERTENSION Non-pharmacological approaches to the control of hypertension There is now a wealth of information indicating that diet, lack of exercise and alcohol consumption may greatly influence arterial pressure in the community.

Purchase Hypertension - 2nd Edition. Print Book & E-Book.

Details Mechanisms and recent advances in therapy of hypertension EPUB

ISBNIn contrast to these advances in therapy, our understanding of the basic mechanisms responsible for the pathogenesis of hypertension remains incomplete. Recent studies have produced new insights into the nature of the regulation of muscle contraction in both heart and blood vessels as well as the changes in muscle function that occur in.

The major advances in pharmacologic treatment of hypertension are (1) the vasodilator-β-blocker combination, (2) the classification of "essential" hypertensives into renin subgroups, 5 and (3) treatment with antihypertensive agents that have been approved by the FDA in recent years.

These include propranolol hydrochloride (Inderal) clonidine hydrochloride (Catapres), diazoxide (Hyperstat. Abstract. Essential hypertension was so named by Frank in 1 and termed hypertensive cardiovascular disease by Janeway in 2 There is evidence that the disease existed in ancient times.

“Hard and bounding pulse” is described variously as an important manifestation of disease in the ancient systems of medicine in China and India; bloodletting was recommended as therapy to lower.

In a recent study, uncontrolled hypertension was found in % of patients, but only % were resistant hypertensives. Patients with resistant hypertension are likely to benefit from evaluation by a hypertension team to assure proper patient identification, diagnostic work-up.

October 5, The American Journal of Medicine NEW CONCEPTS IN HYPERTENSION THERAPY SYMPOSIUM-HOLLENBERG Multiple lines of evidence now suggest that vasocon­striction-a functional disturbance-plays a role in the abnormality of renal perfusion and glomerular filtration rate in patients with essential hypertension.

Pulmonary hypertension is the end-result of a multitude of processes, which are classified into five major categories ().This review will focus primarily on advanced therapy for pulmonary arterial hypertension (PAH), which can occur as an idiopathic illness (IPAH), formerly primary pulmonary hypertension, or in association with other disorders ().

Hypertension may, thus, serve as a biomarker of efficacy of VEGFI therapy, and indeed, studies have demonstrated better outcomes for patients with cancer who develop hypertension with VEGFI treatment.

21 Mechanism of Hypertension During VEGF Inhibition Mechanisms underlying VEGFI-induced hypertension remain unclear. Author(s): Friedman,G D Title(s): Oral contraceptives and hypertension/ G.D. Friedman. In: Liebau, H.

and Brod, J., eds. Mechanisms and recent advances in therapy. Author(s): Liebau,H; Brod,Jan; International Symposium on Nephrology,(4th: Hanover, Germany) Title(s): Mechanisms and recent advances in therapy of.

Recent advances in treatment of htn 1. - Dr. Chandini Rao Moderator: Dr. Nicole Pereira 2. Introduction Drug therapy for HTN • Drugs acting on RAAS - DRIs - ACEIs - ARBs - Vasoactive peptides - Vaccines against RAAS • CCBs • Diuretics • Beta blockers • Misc drugs Combination Rx Rx of Resistant HTN 3.

Advances in genetics and the ability to identify the mutations that result in heritable pulmonary arterial hypertension (PAH) have pinpointed the target mechanisms for new therapies.

This is not “controlling the pathophysiological abnormalities” but introducing therapies that may reverse the structural abnormalities of the disease.

Download Mechanisms and recent advances in therapy of hypertension EPUB

Advances in Pulmonary Hypertension. Advances in Pulmonary Hypertension is PHA’s quarterly medical journal, directed by an editorial board of renowned experts with the oversight of PHA’s Scientific Leadership Council.

Its mission is to help physicians in their clinical decision-making by informing them of important trends affecting their practice and providing an analysis of the impact of.

The current treatment of essential hypertension is based on the following concepts: (1) a single cause has not been identified. Indeed, essential hypertension appears to be a multifactorial disorder. Specific therapy, therefore, is not possible;1 (2) the homeostatic mechanisms that regulate blood pressure are intact in hypertensive subjects and responsive to physiologic and chemical interventions.

JNC 7 criteria for diagnosis of HTN BP classification Blood pressure levels SBP mmHg DBP mmHg Normal hypertension Or Hypertension -I Or Hypertension -II >/= Or >/= 3. Targets of drug action Counter-regulatory mechanisms.

Description Mechanisms and recent advances in therapy of hypertension FB2

2 Hypertension November secondary (HR, ; 95% CI, –) end points without a significant increase in rate of therapy-related adverse events, even though one third of the studied population was consid. A rationale approach to combination therapy in hypertension is the selection of antihypertensive drugs that have complementary mechanisms of action, for example, combining an agent targeting the renin-angiotensin-aldosterone system (RAAS) with a diuretic and.

Journals & Books; Help This would point to two different mechanisms by which captopril causes angioneurotic edema, one as an idiosyncratic reaction and one that is dose-related.

F Gross (Eds.), Recent advances in hypertension therapy: captopril, Excerpta Medica, Amsterdam (), pp. Google Scholar. JK Wilkin, JJ Hammond, WM. Selection of appropriate therapies for pulmonary hypertension is complex and must be carefully chosen according to the etiology and pulmonary vasoreactivity testing during cardiac catheterization.

This review highlights the recent advances in pediatric PH classification and therapy. HR Brunner, F Gross (Eds.), Recent advances in hypertension therapy: captopril.

Presented at the XV International Congress of Internal Medicine, Hamburg, AugExcerpta Medica, Amsterdam (), pp. Recent Advances in Hypertension (Hypertension. ;) Work is ongoing to define the mechanisms, as these seem more and more difficult to show incremental benefit of new therapies over standard therapy in control groups that are on background therapy.

Summary. Pulmonary arterial hypertension complicating systemic sclerosis occurs commonly and portends a poor prognosis. However, recent advances in our understanding of the disease in the context of systemic sclerosis may lead to novel diagnostic and therapeutic strategies that will ultimately improve quality of life and survival in this population.

Various mechanisms for salt-dependent hypertension have been put forward including volume expansion, modified renal functions and disorders in sodium balance, impaired reaction of the renin-angiotensin-aldosterone-system and the associated receptors, central stimulation of the activity of the sympathetic nervous system, and possibly also.

Hypertension, Prehypertension, and Hypertension Control Association With Decline in Cognitive Performance in the ELSA-Brasil Cohort. Sara Teles de Menezes, Luana Giatti, Luisa Campos Caldeira Brant, Rosane Harter Griep, Maria Inês Schmidt, Bruce Bartholow Duncan, Claudia Kimie Suemoto, Antonio Luiz Pinho Ribeiro, Sandhi Maria Barreto.

Nearly half of patients with "stage-2 hypertension" (BP ≥/90 mm Hg) are low-risk (% and % with year risks therapy in younger patients ( years old) or "mild-hypertensives" (BP. Mechanisms of hypertension and hypertension-related organ damage have been explored by a large body of studies.

Four articles focus on the role of several blood pressure (BP) parameters on cardiovascular risk and organ damage.Pathophysiology is a branch of medicine which explains the function of the body as it relates to diseases and conditions. The pathophysiology of hypertension is an area which attempts to explain mechanistically the causes of hypertension, which is a chronic disease characterized by elevation of blood ension can be classified by cause as either essential (also known as primary or.